Daxdilimab

Tax included
Daxdilimab is an anti-ILT7 monoclonal antibody, ILT7 is a cell surface molecule specific to the pDC type of dendritic cells. Daxdilimab can be used in acute lung injury (ALI) in patients with COVID-19 infection research.
MedChemExpress 
HY-P99226

Data sheet

Size
Multiple sizes
Reactivity
SARS-CoV
Application
Cancer-programmed cell death
CAS
2245966-28-1